Document type

Article

Version

Published version

Publication date

Publication license

cc-by (c) Vilariño, Noelia et al., 2020
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/222863

Immune-driven pathogenesis of neurotoxicity after exposure of cancer patients to immune checkpoint inhibitors

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Over the last decade, immune checkpoint inhibitors (ICIs) have revolutionized the treatment of several cancer types. ICIs work through the blockage of immune inhibitory signals, while increasing the T-cell specific immune antitumoral response. However, due to the fact that ICIs' mechanism of action is not tissue antigen-specific and not limited to the tumor microenvironment, the use of cancer immunotherapy can produce a broad range of immune-related adverse events (irAEs). Neurological immune-related adverse events (NirAEs) are rare (the overall incidence varies between 1% to 6%), and these adverse events mainly concern the peripheral nervous system, rather than the central nervous system. Due to their potential severity, which could cause interruptions to cancer treatment, NirAEs are of particular clinical importance. Currently, the pathogenesis of these complications is not completely understood, although T-cells seem to play a principal role. Nevertheless, the development of NirAEs is likely to be a multifactorial and complex process. This conclusion can be extracted from the wide range of neurological auto-inflammatory and autoimmune disorders triggered or exacerbated by ICIs, and the extensive variability of the limited histological findings reported. The aim of this review is to summarize the potential immune-driven pathological mechanisms of NirAEs.

Citation

Citation

VILARIÑO, Noelia, et al. Immune-driven pathogenesis of neurotoxicity after exposure of cancer patients to immune checkpoint inhibitors. International Journal of Molecular Sciences. 2020. Vol. 21, num. 16, pags. 5774. ISSN 1422-0067. [consulted: 14 of June of 2026]. Available at: https://hdl.handle.net/2445/222863

Export metadata

JSON - METS

Share record